Search Results - "Smare, C" :: K.UTB vyhledávací portál

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK

by Vatish, M., Strunz‐McKendry, T., Hund, M., Allegranza, D., Wolf, C., Smare, C.
Published in Ultrasound in obstetrics & gynecology (01.12.2016)

Get full text

Journal Article

Loading…

MSR97 Indirect Estimation of Post-Distant Recurrence Survival (PDRS) for Resected Stage II/III Melanoma: A Network-Meta Analysis (NMA) Approach

by Kurt, M, Toor, K, Zhang, Y, Smare, C, Theriou, C, Chan, K, Srinivasan, S, Moshyk, A, Mohr, P
Published in Value in health (01.06.2024)

Get full text

Journal Article

Loading…

EE280 Budget Impact (BI) of First-Line (1L) Cemiplimab Monotherapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) with Programmed Cell Death-Ligand 1 (PD-L1) ≥50% in a Large US Health Plan: An Updated Analysis

by Quek, RGW, Theriou, C, Smare, C, Keeping, S, Xu, Y, Konidaris, G, LaFontaine, PR, Harnett, J
Published in Value in health (01.07.2022)

Get full text

Journal Article

Loading…

PCN46 - Retrospective Validation of Predicted Long-Term Survival Estimates from an Early Data Cut of the Phase III Checkmate 025 Study in Advanced Renal Cell Carcinoma

by Johal, S, Smare, C, Malcolm, B, Doan, J
Published in Value in health (01.05.2018)

Get full text

Journal Article

Loading…

Retrospective Validation of Predicted Long-Term Survival Estimates from an Early Data Cut of the Phase III Checkmate 025 Study in Advanced Renal Cell Carcinoma

by Johal, S, Smare, C, Malcolm, B, Doan, J
Published in Value in health (01.05.2018)

Get full text

Journal Article

Loading…

PCN181 ACCELERATING EARLY COST-EFFECTIVENESS MODELING IN ONCOLOGY USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A RETROSPECTIVE CASE STUDY OF NIVOLUMAB PRE-TREATED METASTATIC SMALL-CELL LUNG CANCER POPULATION

by Wu, E., Berardi, A., Berling, M., Smare, C., Yuan, Y., Wagner, S.
Published in Value in health (01.11.2019)

Get full text

Journal Article

Loading…

PCN219 WHAT IS WORTH KNOWING AT EARLY DEVELOPMENT? VALUE OF INFORMATION ANALYSIS USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A CASE STUDY

by Wu, E., Berardi, A., Berling, M., Smare, C., Yuan, Y., Wagner, S.
Published in Value in health (01.11.2019)

Get full text

Journal Article

Loading…

EVALUATING PARTITIONED SURVIVAL MODEL AND MARKOV DECISIONANALYTIC MODEL APPROACHES FOR USE IN COST-EFFECTIVENESS ANALYSIS: ESTIMATING AND VALIDATING SURVIVAL OUTCOMES

by Smare, C, Lakhdari, K, Doan, J, Johal, S
Published in Value in health (01.05.2017)

Get full text

Journal Article

Loading…

PCN236 A LANDMARK RESPONSE ANALYSIS TO DETERMINE COST-EFFECTIVENESS OF THIRD-LINE NIVOLUMAB MONOTHERAPY FOR SMALL CELL LUNG CANCER

by Smare, C., Dave, K., Juarez-Garcia, A., Schoenherr, N., Abraham, P., Penrod, J.R., Camidge, D.R., Yuan, Y.
Published in Value in health (01.11.2019)

Get full text

Journal Article

Loading…

PCN227 A PARTITIONED SURVIVAL MODEL TO DETERMINE COST-EFFECTIVENESS OF THIRD-LINE NIVOLUMAB MONOTHERAPY FOR SMALL CELL LUNG CANCER

by Smare, C., Dave, K., Juarez-Garcia, A., Schoenherr, N., Abraham, P., Penrod, J.R., Camidge, D.R., Yuan, Y.
Published in Value in health (01.11.2019)

Get full text

Journal Article

Loading…

PRM157 - THE IMPACT OF LANDMARK RESPONSE ON OVERALL SURVIVAL: IMPLICATIONS FOR THE ECONOMIC EVALUATION OF IMMUNE-THERAPY (I-O) TREATMENT IN SMALL CELL LUNG CANCER (SCLC)

by Santi, I, Smare, C, Juarez-Garcia, A., Camidge, DR, Schoenherr, N, Penrod, JR, Abraham, P, Korytowsky, B, Yuan, Y
Published in Value in health (01.10.2018)

Get full text

Journal Article